Document ID: chunk:federal_register_of_legislation:C2024C00449:section:7:p2
Version: federal_register_of_legislation:C2024C00449
Segment Type: section
Provision Reference: s 7 (pt 2/2)
Character Range: 13049–14224

issued by the CEO of the NHMRC under the National Health and Medical Research Council Act 1992, as existing from time to time; or
 (b) is determined to be unsuitable for implantation in the body of a woman, in accordance with objective criteria specified in guidelines issued by the CEO of the NHMRC under the National Health and Medical Research Council Act 1992 and prescribed by the regulations for the purposes of this paragraph.
use includes develop, or development, as the case requires.
woman means a female human.
 (2) For the purposes of the definition of human embryo in subsection (1), in working out the length of the period of development of a human embryo, any period when the development of the embryo is suspended is to be disregarded.
 (3) A reference in this Act to an embryo (including a human embryo) is a reference to a living embryo.
 (4) A reference in this Act to a human egg is a reference to a human oocyte.
 (5) A reference in this Act to a human embryo does not include a reference to:
 (a) a hybrid embryo; or
 (b) a human embryonic stem cell line.

Part 2—Regulation of the use of excess ART embryos and other material

Division 1—Interpretation